Healthcare Costs That Disappear When People Eat Real Food From Real Soil

The structural argument is this: chronic disease is not a healthcare problem with a food component. It is a food system problem with a healthcare cost. The distinction matters because it determines where intervention should happen.

The Accounting Problem

Conventional healthcare cost accounting treats diet-attributable disease costs as the cost of treatment, which flows through insurance premiums, Medicare and Medicaid expenditures, hospital billing, and pharmaceutical revenues. It does not trace those costs back to their origin in the food system. There is no line item in the federal budget that says "cost of ultra-processed food consumption, 2024: $1.3 trillion." The costs are distributed across millions of individual billing events and insurance claims, making the causal chain invisible in the aggregate accounting.

This is a planning problem. When the costs are invisible, the intervention points are invisible. What gets funded is treatment — the downstream management of conditions that are upstream preventable. Medicare spent approximately $800 billion in 2022, the majority on enrollees with multiple chronic conditions, the majority of those conditions diet-attributable. Medicaid spent approximately $600 billion. The combined direct federal expenditure on diet-attributable chronic disease management likely exceeds $500 billion annually through these programs alone.

The opportunity cost is not just the money. It is the human suffering, productive capacity, cognitive function, and social stability that chronic disease destroys at scale.

The Reversal Evidence

The most powerful cost-elimination argument comes from reversal studies — programs that demonstrate not just slowing of disease progression but actual elimination of disease burden and its associated costs.

Type 2 diabetes reversal is the best-documented case. Virta Health, a telehealth company using nutritional ketosis as the primary intervention, published five-year outcomes data in 2022 showing that 38% of participants achieved complete type 2 diabetes reversal (HbA1c below 6.5% without medication), compared to less than 1% in standard care. Medication costs in the Virta cohort fell by 63% at one year. The intervention cost approximately $700 per patient per year. The average annual cost of conventional type 2 diabetes management in the United States is approximately $9,600. The cost of a single major diabetes complication — a lower limb amputation, a dialysis initiation, a cardiac event — ranges from $30,000 to over $100,000. The math is not complicated.

The PREDIMED trial (Prevención con Dieta Mediterránea), one of the largest nutritional intervention trials in history, randomized approximately 7,500 high-cardiovascular-risk adults to a Mediterranean diet supplemented with olive oil, a Mediterranean diet supplemented with nuts, or a low-fat control diet. After a median follow-up of 4.8 years, both Mediterranean diet groups showed approximately 30% relative risk reduction in major cardiovascular events. Published in the New England Journal of Medicine in 2013, this trial established a level of evidence for dietary intervention in cardiovascular disease that should have reorganized cardiology practice and insurance coverage. It has not, substantially, because the medical system is structured to pay for procedures and pharmaceuticals, not dietary intervention.

The Soil Connection: What Mineral Depletion Costs

The link between soil health and human health operates through several pathways:

Micronutrient density is directly determined by soil mineral availability. Selenium deficiency — associated with impaired thyroid function, reduced antioxidant capacity, and compromised immune response — tracks with soil selenium content. Regions of the United States with selenium-poor soils show higher rates of selenium deficiency in residents who eat locally grown food. Iodine is similar; inland regions far from marine sources and without iodized salt access show elevated thyroid disorder prevalence. Zinc deficiency, estimated to affect approximately two billion people globally, impairs immune function, wound healing, and neurodevelopment, and correlates with zinc-depleted agricultural soils.

The USDA Nutrient Database has tracked changes in food nutrient content since the 1950s. A frequently cited 2004 paper by Donald Davis and colleagues in the Journal of the American College of Nutrition compared nutrient content of 43 garden crops in 1950 versus 1999 and found statistically reliable declines in protein, calcium, phosphorus, iron, riboflavin, and ascorbic acid. The decline was attributed to agricultural practices that prioritize yield over nutrient density — specifically, the selection of high-yield varieties that grow faster and produce more biomass without proportionally greater mineral uptake, and continuous cropping on soils whose mineral content is replenished with only NPK (nitrogen, phosphorus, potassium) rather than the full mineral spectrum.

This is not a completed research question. Some researchers argue that the declines are smaller than Davis found or attributable to measurement methodology changes. But the directional claim — that industrial agriculture has reduced the nutritional density of the food supply while increasing its caloric delivery — is consistent with mechanistic understanding of soil biology and plant physiology.

Crop Insurance, Subsidy Structures, and Perverse Incentives

The U.S. federal agricultural subsidy system spent approximately $16.5 billion in 2022, the majority supporting corn, soybeans, wheat, cotton, and rice — commodity crops that form the raw material inputs for the ultra-processed food system. Fruit and vegetable production receives a small fraction of subsidy support. Crop insurance — the largest component of farm support — heavily subsidizes commodity crop production, reducing the risk of commodity farmers while leaving specialty crop (fruit and vegetable) farmers without comparable risk management tools.

The effect is to make commodity-derived ultra-processed food artificially cheap relative to fruits and vegetables. Researchers at the Center for Science in the Public Interest estimated in 2019 that if the healthcare costs associated with subsidy-supported commodity crops were internalized into food prices, the cost structure of the food system would look radically different. The cheap burger and the expensive salad reflect subsidy policy as much as production reality.

A planned agricultural system that recognized healthcare as a downstream output of farming decisions would subsidize differently. It would price support crops according to their nutritional and ecological value, not their commodity market volume. It would fund agricultural research into high-nutrient-density varieties and regenerative growing practices proportionally to the healthcare savings they could generate. None of this is technically complex. All of it is politically contested because the beneficiaries of the current system have significant lobbying presence and the beneficiaries of a redesigned system — future patients who will not develop preventable disease — have no lobbying presence at all.

The Cost Disappearance Model

What does it look like when healthcare costs disappear at scale from dietary improvement? The best available natural experiments come from countries or regions that have implemented comprehensive food system interventions:

Finland's North Karelia project (1972-1997) reduced cardiovascular mortality by 80% in the intervention region through a multi-pronged food system intervention. Nationally, Finland reduced cardiovascular disease mortality by over 60% across the same period. The healthcare cost savings were substantial, though they were not the primary motivation — the motivation was that North Karelia had the highest coronary heart disease mortality rate in the world and the population demanded action.

Japan's dietary transition runs the experiment in reverse: as Western ultra-processed foods have penetrated Japanese diets since the 1980s, rates of obesity, type 2 diabetes, and some cancers have risen from their historically very low base. The healthiest cohorts in Japan remain those who maintain traditional dietary patterns — high fish intake, diverse fermented foods, low ultra-processed food consumption, high vegetable intake. Their healthcare utilization and longevity outcomes remain exceptional.

The cost disappearance from real food is not total or instant. Some diseases will occur regardless of diet. Some people will not respond to dietary intervention. The transition has its own costs: agricultural system redesign, food pricing changes, distribution infrastructure investment. But the directional claim is supported: a food system that delivers nutrient-dense real food grown in biologically active soil would generate a substantially lower burden of diet-attributable chronic disease, and the healthcare costs of that burden would contract accordingly.

The planning question is not whether this is true. It is whether the political economy can be reorganized to fund the prevention rather than the cure. That requires someone to name the cost at the source, which means tracing healthcare expenditure back to soil management, crop subsidies, and food processing standards — a chain of causation that most of the institutions involved in any one link prefer not to follow all the way to its end.